摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(3-甲氧基苄基)-1-丙胺 | 764651-75-4

中文名称
N-(3-甲氧基苄基)-1-丙胺
中文别名
(3-甲氧基苄基)丙基-1-胺
英文名称
N-propyl-N-(3-methoxybenzyl)amine
英文别名
N-(3-methoxybenzyl)propylamine;N-(3-Methoxybenzyl)propan-1-amine;N-[(3-methoxyphenyl)methyl]propan-1-amine
N-(3-甲氧基苄基)-1-丙胺化学式
CAS
764651-75-4
化学式
C11H17NO
mdl
MFCD07410194
分子量
179.262
InChiKey
UDBXJQKNGYJALH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    100 °C(Press: 0.6 Torr)
  • 密度:
    0.953±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    13
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.454
  • 拓扑面积:
    21.3
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:075d447ce1ecb17846a8f67fc23bfe58
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-(3-甲氧基苄基)-1-丙胺3-(4-methyl-6-dimethylaminopyridin-3-yl)-2,5-dimethyl-7-chloropyrazolo[1,5-a]pyrimidine乙腈 为溶剂, 以19 mg的产率得到[3-(6-Dimethylamino-4-methyl-pyridin-3-yl)-2,5-dimethyl-pyrazolo[1,5-a]pyrimidin-7-yl]-(3-methoxy-benzyl)-propyl-amine
    参考文献:
    名称:
    Design of 2,5-Dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-a]pyrimidine (NBI 30775/R121919) and Structure−Activity Relationships of a Series of Potent and Orally Active Corticotropin-Releasing Factor Receptor Antagonists
    摘要:
    We have previously shown that 3-phenylpyrazolo[1,5-a]pyrimidines exemplified by 8 were potent antagonists of the human corticotropin-releasing factor-1 receptor. A series of 3-pyridylpyrazolo[1,5-a]pyrimidines 15, 25-30, 34, and 35 containing a weakly basic pyridine ring at the 3-position of the bicyclic nucleus was designed to reduce lipophilicity from the initial leads such as 7. Here, we showed that these 3-pyridyl compounds exhibited potent antagonists at the human CRF1, receptor. Moreover, the hydrophilic and weakly basic pyridine moiety increased the water solubility of some analogues. Compound 26h exhibited good binding affinity at the human CRF1 receptor with a K-i value of 3.5 nM. As a functional antagonist, it dose-dependently inhibited CRF-stimulated cAMP production in cells expressing the CRF1 receptor [IC50 = 50 nM), and CRF-stimulated ACTH release from cultured rat pituitary cells [IC50 = 20 nM). 26h had a log P value of 4.9 and water solubility of greater than 10 mg/mL. Pharmacokinetic studies in rats showed that 26h was orally bioavailable and able to penetrate into the brain. 26h has been demonstrated in vivo efficacy in animal behavioral models that measure anxiolytic activity. These results suggest that analogues from this series were potent CRF1, receptor antagonists with proper physicochemical properties and good pharmacokinetic profiles. 26h was developed into a clinical compound and exhibited efficacy in patients with major depression.
    DOI:
    10.1021/jm040058e
  • 作为产物:
    描述:
    [1-(3-Methoxy-phenyl)-meth-(E)-ylidene]-propyl-amine 在 sodium tetrahydroborate 作用下, 以 甲醇 为溶剂, 反应 1.0h, 以1.73 g的产率得到N-(3-甲氧基苄基)-1-丙胺
    参考文献:
    名称:
    Preparation of Benzolactams by Pd(OAc)2-Catalyzed Direct Aromatic Carbonylation
    摘要:
    We developed a new method for Pd(II)-catalyzed direct aromatic carbonylation in a phosphine-free catalytic system using Pd(OAc)2 and Cu(OAc)2 in an atmosphere of CO gas containing air. The carbonylation proceeded with ortho-palladation, inducing a remarkable site selectivity to afford a variety of five- or six-membered benzolactams from secondary omega-arylalkylamines, such as N-alkylbenzylamines or N-alkylphenethylamines.
    DOI:
    10.1021/ja045342+
点击查看最新优质反应信息

文献信息

  • Highly economical and direct amination of sp<sup>3</sup> carbon using low-cost nickel pincer catalyst
    作者:Andrew Brandt、Ambar B. RanguMagar、Peter Szwedo、Hunter A. Wayland、Charlette M. Parnell、Pradip Munshi、Anindya Ghosh
    DOI:10.1039/d0ra09639c
    日期:——
    first time, we report the use of an amide-based nickel pincer catalyst (1) for direct alkylation of amines via activation of sp3 C-H bonds. The reaction was accomplished using a 0.2 mol% catalyst and no additional activating agents other than the base. Upon optimization, it was determined that the ideal reaction conditions involved solvent dimethyl sulfoxide at 110 °C for 3 h. The catalyst demonstrated
    开发更有效的途径来实现 CN 键偶联对于从药品和肥料产品到生物医学技术和下一代电活性材料等行业都具有重要意义。在过去的十年中,催化剂设计的改进已经将合成从昂贵的金属转移到通过直接胺烷基化的新型廉价的CN交叉偶联方法。我们首次报道了使用基于酰胺的镍钳形催化剂 (1) 通过 sp3 CH 键的活化来直接烷基化胺。该反应使用 0.2 mol% 催化剂完成,除碱外没有其他活化剂。经优化,确定理想的反应条件为溶剂二甲亚砜,110 ℃反应3 h。该催化剂在各种亚胺、分子内环化胺和取代胺的形成中表现出优异的反应活性,周转数 (TON) 高达 183。根据反应所用的碱和起始胺,该催化剂表现出对产品的形成。对反应途径机理和动力学的探索表明,CH活化是限速步骤,反应整体为二阶,对催化剂和甲苯底物保持一阶行为。
  • Pd(OAc)<sub>2</sub>-Catalyzed Carbonylation of Amines
    作者:Kazuhiko Orito、Mamoru Miyazawa、Takatoshi Nakamura、Akiyoshi Horibata、Harumi Ushito、Hideo Nagasaki、Motoki Yuguchi、Satoshi Yamashita、Tetsuro Yamazaki、Masao Tokuda
    DOI:10.1021/jo060612n
    日期:2006.8.1
    phenethylamine derivatives, underwent a direct aromatic carbonylation to afford five- or six-membered benzolactams. In the carbonylation, the chelation effect or steric repulsion between Pd(II) and the meta-substituent in the ortho-palladation and the ring sizes of cyclopalladation products that were formed prior to carbonylation were found to generate good site selectivity and increase the reaction rate. In
    无膦的催化体系[Pd(OAc)2 -Cu(OAc)2-空气]在沸腾的甲苯中,在CO气体(1个大气压)下引发了胺的底物特异性羰基化。通过伯胺的羰基化获得对称的N,N'-二烷基脲。N,N,N′-三烷基脲通过向上述反应容器中添加仲胺而选择性地形成。仲胺不产生四烷基脲。但是,在烷基链上带有苯基的二烷基胺,例如N-对单烷基化的苄胺或苯乙胺衍生物进行直接的芳族羰基化反应,得到五元或六元的苯并内酰胺。在羰基化反应中,发现Pd(II)与邻位钯的间位取代基之间的螯合效应或位阻以及羰基化之前形成的环钯的产物的环大小可产生良好的位点选择性并提高反应速率。相反,具有羟基的ω-芳基烷基胺的羰基化既不产生脲也没有苯并内酰胺,而是平稳地产生1,3-恶唑烷酮。在所用条件下,胺的盐酸盐也进行羰基化,得到相应的酰胺。该程序使得可以制备氨基酸酯的脲和实际收率的N-烷基氨基甲酸酯。
  • One-pot, chemoselective synthesis of secondary amines from aryl nitriles using a PdPt–Fe<sub>3</sub>O<sub>4</sub> nanoparticle catalyst
    作者:Jin Hee Cho、Sangmoon Byun、Ahra Cho、B. Moon Kim
    DOI:10.1039/d0cy00630k
    日期:——
    unsymmetrical secondary amines under mild conditions. However, aryl nitriles containing an electron-donating substituent were rather resistant to the reductive amination, and when hexafluoroisopropanol (HFIP) was used as a co-solvent, the reaction selectivity and yield for unsymmetrical secondary amines increased dramatically. Using the catalyst system, one-pot, gram-scale synthesis of indole was possible
    我们已经开发了一种新的催化方法,用于通过PdPt-Fe 3 O 4纳米颗粒(NP)催化剂通过芳基腈与硝基烷烃的还原胺化反应,实现不对称仲胺的一锅级联反应。与单金属Pd–Fe 3 O 4或Pt–Fe 3 O 4相比,双金属催化剂的使用提高了反应性和选择性。NP催化剂。使用这种双金属催化体系,我们成功地在温和条件下合成了各种不对称仲胺。然而,含有给电子取代基的芳基腈相当耐还原胺化,当使用六氟异丙醇(HFIP)作为助溶剂时,不对称仲胺的反应选择性和收率大大提高。使用催化剂体系,可以由2-硝基苯基乙腈一锅克级地合成吲哚。由于Fe 3 O 4载体的磁性,双金属催化剂可以容易地使用外部磁体至少循环四次。
  • Process for the production of isoindoline derivatives, novel intermediates and process for their production
    申请人:Banyu Pharmaceutical Co., Ltd.
    公开号:EP0275064A2
    公开(公告)日:1988-07-20
    A process for producing a compound of the formula: wherein R¹ is a hydrogen atom, a lower alkyl group or an aralkyl group, and R² is a hydrogen atom or a hydroxyl-protecting group, or a salt thereof, which comprises removing from a compound of the formula: wherein R³ is a hydrogen atom or a hydroxyl-protecting group, R⁴ and R⁵ which may be the same or different are N-protecting groups selected from the group consisting of lower alkyl groups and aralkyl groups, and X⊖ is an anion, the N-protecting group(s), if necessary, together with the hydroxyl-protecting group.
    一种生产式化合物的工艺: 其中R¹为氢原子、低级烷基或芳烷基,R²为氢原子或羟基保护基,或其盐的工艺,包括从式化合物中除去 其中 R³ 是氢原子或羟基保护基团,R⁴ 和 R⁵ 可以相同或不同,是选自由低级烷基和芳烷基组成的组的 N 保护基团,X⊖ 是阴离子。
  • Biarylurea derivatives
    申请人:Hayama Takashi
    公开号:US20070027147A1
    公开(公告)日:2007-02-01
    The present invention relates to a compound of Formula (I) and the manufacturing method(s) thereof and the use thereof: Formula (I) wherein: Ar is a nitrogen-containing heteroaromatic ring group; X and Z are each a carbon atom, and so on; Y is CO, and so on; R 1 is a hydrogen atom, and so on; R 2 and R 3 are each a hydrogen atom, and so on; R 4 and R 5 are each a hydrogen atom, and so on; and the formula is a single bond or a double bond. According to the present invention, the compound of the present invention can provide Cdk4 and/or Cdk6 inhibitors for treating malignant tumors, because the compounds of the present invention exhibit a prominent growth inhibitory activity against tumor cells.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐